2034年全球输液帮浦电子市场预测－按泵浦类型、应用、最终用户和地区分類的全球分析

根据 Stratistics MRC 预测，全球输液帮浦电子市场规模预计将在 2026 年达到 21 亿美元，并在预测期内以 9.0% 的复合年增长率成长，到 2034 年达到 43 亿美元。

输液帮浦电子元件是指输液帮浦和携带式输液装置中用于调节和监测药物控制输注的电子机制。这些系统通常由处理器、感测元件、电源控制单元和通讯介面组成，它们协同工作以确保输注的准确性和运作安全性。对先进泵浦电子元件的需求不断增长，主要源于医疗保健需求的增加，尤其是对糖尿病、癌症和慢性疼痛等疾病长期治疗的需求。现代设备还支援无线通讯和与数位健康平台的集成，从而实现即时监测和更完善的患者管理。小型化电子元件、节能电池和智慧安全机制的不断进步，推动了可靠且用户友好的输液泵技术的发展。

根据国际糖尿病联盟（IDF）的数据，预计到 2030 年，全球糖尿病患者人数将达到 6.43 亿，这将直接推动胰岛素帮浦和智慧注射器等电子药物输送系统的发展。

慢性病盛行率增加

糖尿病、癌症、心血管疾病和神经系统疾病等慢性病患者人数的不断增加，显着推动了对输液帮浦电子设备的需求。长期病患通常需要精准且持续的药物输注，而现代输液帮浦能够有效率地满足这项需求。这些设备内部的电子元件能够调节剂量精度、监测安全参数并维持稳定运作。随着全球人口老化和文明病的日益增多，医疗保健系统对自动化药物输注技术的应用也日益广泛。

高昂的研发和製造成本

药物输送泵电子市场的主要限制因素之一是复杂电子系统的设计和製造成本高。这些帮浦依靠高精度感测器、先进的微控制器和可靠的监控电路来确保药物安全、精准地输送。实施这些技术需要大量的研发、专门的製造流程和严格的测试程序，增加了整体製造成本。此外，满足严格的法规和安全要求也会给製造商带来额外的财务负担。对于小规模的公司而言，投资如此昂贵的研发流程可能十分困难。

穿戴式药物输送装置的扩展

穿戴式药物输送技术的日益普及，为药物输送泵电子元件市场创造了强劲的成长潜力。穿戴式输注系统使患者能够持续接受药物治疗，而无需限制其行动或日常活动。这些设备依靠先进的电子元件来控制剂量精度、监测性能并保持高效的电力消耗。人们对便捷治疗方法的日益关注，尤其是在糖尿病和其他慢性疾病的管理方面，正在推动穿戴式解决方案的普及。更小的电路、更先进的感测器技术和更高的电池效率进一步促进了产品创新。随着个人化行动医疗的日益普及，可穿戴药物输送泵电子元件市场预计将快速成长。

产品召回和安全问题增多

设备召回和安全问题日益增多，对输液帮浦电子市场构成重大风险。这些帮浦依赖精密的电子元件来精确输送药物。软体、感测器或电子控制系统的故障可能导致剂量错误，危及患者健康。一旦出现此类问题，製造商可能面临强制召回、法律诉讼和声誉损害。监管机构也正在针对安全问题进行严格评估。这些措施可能会降低医疗专业人员和使用者的信心。因此，反覆的召回和安全问题可能会对输液帮浦先进电子元件的普及和发展产生负面影响。

新冠疫情的影响：

新冠疫情为输液帮浦电子市场带来了挑战和成长机会。初期，全球供应链中断、工厂关闭以及半导体元件短缺影响了输液帮浦及相关电子系统的生产。儘管面临这些挑战，医院对用于治疗需要持续输液和液体疗法的紧急医疗设备的需求却激增。在这场公共卫生危机中，输液帮浦在加护病房发挥了至关重要的作用。此外，疫情期间对远端患者监护和居家医疗服务的日益重视也推动了输液帮浦采用技术先进、数位化连接的电子系统。

在预测期内，输液帮浦细分市场预计将占据最大的市场份额。

由于输液帮浦在医疗机构和居家照护中广泛用于药物和液体的管理和输注，预计在预测期内，输液帮浦细分市场将占据最大的市场份额。这些设备依赖先进的电子元件来确保精准的药物输送、运作监测和病人安全。输液帮浦广泛应用于重症监护、外科手术、肿瘤治疗和长期疾病管理等领域。它们能够提供持续或定时的药物输送，使其成为医疗专业人员的宝贵设备。随着医院越来越多地采用自动化药物输送技术来提高治疗效率，输液帮浦将继续保持其市场主导地位。

在预测期内，糖尿病管理细分市场预计将呈现最高的复合年增长率。

在预测期内，糖尿病管理领域预计将呈现最高的成长率，这主要归因于全球糖尿病患者人数的不断增加。电子输注帮浦被广泛用于确保胰岛素的精准输注，并帮助维持血糖值的稳定性。这些系统减少了频繁注射的需要，使患者的长期疾病管理更加便捷。人们对自动化胰岛素输注设备、穿戴式治疗方案和数位化互联监测技术的兴趣日益浓厚，推动了这些技术的应用。科技的持续进步和对高效糖尿病护理解决方案的需求，极大地促进了该领域的快速发展。

市占率最大的地区：

在预测期内，北美预计将占据最大的市场份额，这主要得益于其高度发达的医疗保健体系、先进医疗技术的广泛应用以及众多大型医疗设备公司的存在。该地区的医疗服务提供者越来越依赖电子输液帮浦来确保药物的精准给药并改善患者照护。慢性病患者数量的不断增长也推动了对先进输液技术的强劲需求。此外，有利的监管标准、持续的技术进步以及对医疗创新的巨额投资，都巩固了该地区的领先地位，并使其在全球市场中保持着较高的份额。

复合年增长率最高的地区：

在预测期内，随着医疗保健体系的持续发展和现代医疗技术的日益普及，亚太地区预计将呈现最高的复合年增长率。人口成长、对先进治疗方法的认知度不断提高以及慢性病负担日益加重，都在推动对自动化药物输送解决方案的需求。许多国家的政府正致力于加强医疗基础建设，并推广创新医疗设备的使用。医院扩建、医疗服务可近性的提升以及人们对居家照护方案日益增长的兴趣，都进一步促进了市场成长。预计这些趋势将显着加速亚太地区泵类电子产品的成长。

免费客製化服务：

所有购买此报告的客户均可享受以下免费自订选项之一：

• 企业概况
  • 对其他市场参与者（最多 3 家公司）进行全面分析
  • 对主要企业进行SWOT分析（最多3家公司）
• 区域细分
  • 应客户要求，我们提供主要国家和地区的市场估算和预测，以及复合年增长率（註：需进行可行性检查）。
• 竞争性标竿分析
  • 根据产品系列、地理覆盖范围和策略联盟对主要企业进行基准分析。

目录

第一章执行摘要

• 市场概览及主要亮点
• 驱动因素、挑战与机会
• 竞争格局概述
• 战略洞察与建议

第二章：研究框架

• 研究目标和范围
• 相关人员分析
• 研究假设和限制
• 调查方法

第三章 市场动态与趋势分析

• 市场定义与结构
• 主要市场驱动因素
• 市场限制与挑战
• 投资成长机会和重点领域
• 产业威胁与风险评估
• 技术与创新展望
• 新兴市场/高成长市场
• 监管和政策环境
• 新冠疫情的影响及復苏前景

第四章：竞争环境与策略评估

• 波特五力分析
  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的竞争
• 主要企业市占率分析
• 产品基准评效和效能比较

第五章：全球输液帮浦电子市场：依帮浦类型划分

• 注射式帮浦
• 点滴帮浦
• 嵌入式泵浦
• 胰岛素帮浦
• 弹性体泵

第六章：全球药物输送帮浦电子市场：依应用领域划分

• 糖尿病管理
• 肿瘤学
• 疼痛管理
• 心血管疾病
• 神经病学
• 胃肠病学
• 感染疾病

第七章 全球药物输送帮浦电子市场：依最终用户划分

• 医院和诊所
• 门诊手术中心
• 居家医疗环境
• 专业医疗中心

第八章 全球输液帮浦电子市场：依地区划分

• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 荷兰
  • 比利时
  • 瑞典
  • 瑞士
  • 波兰
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 印尼
  • 泰国
  • 马来西亚
  • 新加坡
  • 越南
  • 其他亚太国家
• 南美洲
  • 巴西
  • 阿根廷
  • 哥伦比亚
  • 智利
  • 秘鲁
  • 其他南美国家
• 世界其他地区（RoW）
  • 中东
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 以色列
    • 其他中东国家
  • 非洲
    • 南非
    • 埃及
    • 摩洛哥
    • 其他非洲国家

第九章 战略市场资讯

• 工业价值网络和供应链评估
• 空白区域和机会地图
• 产品演进与市场生命週期分析
• 通路、经销商和打入市场策略的评估

第十章：产业趋势与策略倡议

• 併购
• 伙伴关係、联盟和合资企业
• 新产品发布和认证
• 扩大生产能力和投资
• 其他策略倡议

第十一章：公司简介

• Medtronic plc
• Becton, Dickinson and Company
• Baxter International Inc.
• B. Braun Melsungen AG
• Tandem Diabetes Care, Inc.
• Ypsomed AG
• Insulet Corporation
• Novo Nordisk
• Eli Lilly and Company
• West Pharmaceutical Services
• Gerresheimer
• Fresenius Kabi AG
• Debiotech SA
• Flowonix Medical, Inc.
• AstraZeneca plc
• Smiths Medical
• Stevanato Group
• Epsilon Electronics

According to Stratistics MRC, the Global Drug Delivery Pump Electronics Market is accounted for $2.1 billion in 2026 and is expected to reach $4.3 billion by 2034 growing at a CAGR of 9.0% during the forecast period. Drug delivery pump electronics refer to the electronic mechanisms responsible for regulating and supervising the controlled dispensing of medications in infusion pumps and portable drug delivery devices. These systems typically consist of processors, sensing elements, power control units, and communication interfaces that work together to maintain dosing precision and operational safety. Rising healthcare needs, especially for long-term treatment of conditions such as diabetes, cancer, and chronic pain, is increasing the demand for advanced pump electronics. Modern devices also support wireless communication and integration with digital health platforms, enabling real-time monitoring and improved patient management. Ongoing advancements in compact electronic components, energy-efficient batteries, and intelligent safety mechanisms are supporting the development of highly reliable and user-friendly drug delivery pump technologies.

According to the International Diabetes Federation (IDF), the global diabetes prevalence is expected to rise to 643 million by 2030, which directly supports the growth of electronic drug delivery systems like insulin pumps and smart injectors.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The growing number of people affected by chronic health conditions including diabetes, cancer, cardiovascular diseases, and neurological disorders is significantly boosting the demand for drug delivery pump electronics. Individuals with long-term illnesses often require precise and continuous medication delivery, which modern infusion pumps can provide efficiently. The electronic components within these devices regulate dosage accuracy, monitor safety parameters, and maintain consistent operation. With aging populations and increasing lifestyle-related health challenges worldwide, healthcare systems are adopting automated drug delivery technologies more frequently.

Restraint:

High development and manufacturing costs

One significant limitation in the drug delivery pump electronics market is the substantial cost involved in designing and producing sophisticated electronic systems. These pumps rely on highly precise sensors, advanced microcontrollers, and dependable monitoring circuits to ensure safe and accurate medication delivery. Implementing these technologies requires extensive research, specialized manufacturing processes, and rigorous testing procedures, which increase overall production costs. Additionally, meeting strict regulatory and safety requirements adds further financial pressure on manufacturers. Smaller companies may find it difficult to invest in such expensive development processes.

Opportunity:

Expansion of wearable drug delivery devices

The growing popularity of wearable drug delivery technologies offers strong growth potential for the drug delivery pump electronics market. Wearable infusion systems enable patients to receive medications continuously without restricting movement or everyday routines. These devices depend on advanced electronic components to control dosage precision, monitor performance, and maintain efficient power consumption. Increasing interest in convenient treatment options, especially for managing diabetes and other chronic conditions, is encouraging wider adoption of wearable solutions. Improvements in compact circuitry, sensor technology, and battery efficiency are further supporting product innovation. As personalized and mobile healthcare becomes more common, wearable drug delivery pump electronics are likely to expand rapidly.

Threat:

Increasing product recalls and safety incidents

Rising cases of device recalls and safety-related issues pose a major risk to the drug delivery pump electronics market. These pumps depend on sophisticated electronic components to administer medications with high precision. Failures in software, sensors, or electronic control systems may cause incorrect dosage delivery, potentially endangering patient health. When such problems occur, manufacturers may face mandatory product recalls, legal consequences, and reputational damage. Regulatory authorities also conduct strict evaluations following safety concerns. These developments can decrease confidence among healthcare providers and users. As a result, repeated recalls and safety problems may negatively influence the adoption and growth of advanced pump electronics.

Covid-19 Impact:

The COVID-19 pandemic created both challenges and growth opportunities for the drug delivery pump electronics market. Initially, global supply chain interruptions, factory closures, and shortages of semiconductor components affected the manufacturing of infusion pumps and related electronic systems. Despite these challenges, hospitals experienced a surge in demand for critical care devices to treat patients requiring constant medication delivery and fluid therapy. Infusion pumps played an important role in intensive care settings during the health crisis. Moreover, the increased focus on remote patient monitoring and home healthcare services during the pandemic encouraged the adoption of technologically advanced and digitally connected drug delivery pump electronic systems.

The infusion pumps segment is expected to be the largest during the forecast period

The infusion pumps segment is expected to account for the largest market share during the forecast period because of their extensive application in medical facilities and home-based care for controlled drug and fluid administration. These devices depend on sophisticated electronic components to ensure precise medication delivery, operational monitoring, and patient safety. Infusion pumps are widely utilized in critical care environments, surgical treatments, oncology therapy, and long-term disease management. Their capability to provide continuous or scheduled medication dosing makes them highly valuable for healthcare professionals. As hospitals increasingly adopt automated drug administration technologies to enhance treatment efficiency, infusion pumps continue to maintain a leading position in the market.

The diabetes management segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the diabetes management segment is predicted to witness the highest growth rate, mainly because of the increasing number of individuals affected by diabetes worldwide. Electronic drug delivery pumps are widely used to deliver accurate insulin doses and assist in maintaining stable glucose levels. These systems reduce the need for frequent injections and make long-term disease management more convenient for patients. Growing interest in automated insulin delivery devices, wearable treatment solutions, and digitally connected monitoring technologies is encouraging wider adoption. Ongoing technological advancements and the need for efficient diabetes care solutions are significantly supporting the rapid expansion of this segment.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share because of its well-developed healthcare systems, widespread use of modern medical technologies, and the presence of major medical device companies. Healthcare institutions across the region increasingly rely on electronic drug delivery pumps to ensure precise medication administration and enhance patient care. The rising number of patients suffering from chronic illnesses also contributes to the strong demand for advanced drug delivery technologies. Furthermore, supportive regulatory standards, ongoing technological advancements, and substantial investments in healthcare innovation strengthen the region's leadership and maintain its significant share in the global market.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR as healthcare systems continue to develop and modern medical technologies gain wider acceptance. Increasing population levels, greater awareness about advanced treatments, and the growing burden of chronic illnesses are driving demand for automated drug delivery solutions. Many governments are focusing on strengthening healthcare infrastructure and encouraging the use of innovative medical equipment. The expansion of hospitals, improved access to healthcare services, and rising interest in home-based treatment options are further supporting market expansion. These developments are expected to significantly accelerate the growth of pump electronics in Asia-Pacific.

Key players in the market

Some of the key players in Drug Delivery Pump Electronics Market include Medtronic plc, Becton, Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Tandem Diabetes Care, Inc., Ypsomed AG, Insulet Corporation, Novo Nordisk, Eli Lilly and Company, West Pharmaceutical Services, Gerresheimer, Fresenius Kabi AG, Debiotech SA, Flowonix Medical, Inc., AstraZeneca plc, Smiths Medical, Stevanato Group and Epsilon Electronics

Key Developments:

In February 2026, Medtronic has agreed to acquire CathWorks, an Israeli medtech company focused on the diagnosis and treatment of coronary artery disease, for up to $585 million. CathWorks is known for its FFRangio technology, which uses advanced artificial intelligence (AI) algorithms and computational science to obtain fractional flow reserve (FFR) measurements of the coronary tree from routine X-ray images.

In September 2025, Becton Dickinson Korea said that it signed a tripartite strategic memorandum of understanding with BD Global and Celltrion Pharm at the latter's research institute in Songdo, Incheon, for contract manufacturing organization (CMO) cooperation on prefilled syringes (PFS). Through this agreement, the three companies plan to collaborate by connecting and guiding business opportunities for pharmaceutical companies requiring PFS CMO services, leveraging BD's global syringe customer network and Celltrion Pharm's production capabilities.

In June 2025, Baxter International Inc. announced on the signing of an amended and restated five-year credit agreement, increasing its borrowing capacity to $2.2 billion. According to InvestingPro analysis, the company appears undervalued based on its Fair Value metrics. This move amends the existing $2 billion revolving credit facility, and replaces a €200 million credit facility that was terminated concurrently with the new agreement.

Pump Types Covered:

• Syringe Pumps
• Infusion Pumps
• Implantable Pumps
• Insulin Pumps
• Elastomeric Pumps

Applications Covered:

• Diabetes Management
• Oncology
• Pain Management
• Cardiovascular Disorders
• Neurology
• Gastroenterology
• Infectious Diseases

End Users Covered:

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Specialty Centers

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Drug Delivery Pump Electronics Market, By Pump Type

• 5.1 Syringe Pumps
• 5.2 Infusion Pumps
• 5.3 Implantable Pumps
• 5.4 Insulin Pumps
• 5.5 Elastomeric Pumps

6 Global Drug Delivery Pump Electronics Market, By Application

• 6.1 Diabetes Management
• 6.2 Oncology
• 6.3 Pain Management
• 6.4 Cardiovascular Disorders
• 6.5 Neurology
• 6.6 Gastroenterology
• 6.7 Infectious Diseases

7 Global Drug Delivery Pump Electronics Market, By End User

• 7.1 Hospitals & Clinics
• 7.2 Ambulatory Surgical Centers
• 7.3 Home Care Settings
• 7.4 Specialty Centers

8 Global Drug Delivery Pump Electronics Market, By Geography

• 8.1 North America
  • 8.1.1 United States
  • 8.1.2 Canada
  • 8.1.3 Mexico
• 8.2 Europe
  • 8.2.1 United Kingdom
  • 8.2.2 Germany
  • 8.2.3 France
  • 8.2.4 Italy
  • 8.2.5 Spain
  • 8.2.6 Netherlands
  • 8.2.7 Belgium
  • 8.2.8 Sweden
  • 8.2.9 Switzerland
  • 8.2.10 Poland
  • 8.2.11 Rest of Europe
• 8.3 Asia Pacific
  • 8.3.1 China
  • 8.3.2 Japan
  • 8.3.3 India
  • 8.3.4 South Korea
  • 8.3.5 Australia
  • 8.3.6 Indonesia
  • 8.3.7 Thailand
  • 8.3.8 Malaysia
  • 8.3.9 Singapore
  • 8.3.10 Vietnam
  • 8.3.11 Rest of Asia Pacific
• 8.4 South America
  • 8.4.1 Brazil
  • 8.4.2 Argentina
  • 8.4.3 Colombia
  • 8.4.4 Chile
  • 8.4.5 Peru
  • 8.4.6 Rest of South America
• 8.5 Rest of the World (RoW)
  • 8.5.1 Middle East
    • 8.5.1.1 Saudi Arabia
    • 8.5.1.2 United Arab Emirates
    • 8.5.1.3 Qatar
    • 8.5.1.4 Israel
    • 8.5.1.5 Rest of Middle East
  • 8.5.2 Africa
    • 8.5.2.1 South Africa
    • 8.5.2.2 Egypt
    • 8.5.2.3 Morocco
    • 8.5.2.4 Rest of Africa

9 Strategic Market Intelligence

• 9.1 Industry Value Network and Supply Chain Assessment
• 9.2 White-Space and Opportunity Mapping
• 9.3 Product Evolution and Market Life Cycle Analysis
• 9.4 Channel, Distributor, and Go-to-Market Assessment

10 Industry Developments and Strategic Initiatives

• 10.1 Mergers and Acquisitions
• 10.2 Partnerships, Alliances, and Joint Ventures
• 10.3 New Product Launches and Certifications
• 10.4 Capacity Expansion and Investments
• 10.5 Other Strategic Initiatives

11 Company Profiles

• 11.1 Medtronic plc
• 11.2 Becton, Dickinson and Company
• 11.3 Baxter International Inc.
• 11.4 B. Braun Melsungen AG
• 11.5 Tandem Diabetes Care, Inc.
• 11.6 Ypsomed AG
• 11.7 Insulet Corporation
• 11.8 Novo Nordisk
• 11.9 Eli Lilly and Company
• 11.10 West Pharmaceutical Services
• 11.11 Gerresheimer
• 11.12 Fresenius Kabi AG
• 11.13 Debiotech SA
• 11.14 Flowonix Medical, Inc.
• 11.15 AstraZeneca plc
• 11.16 Smiths Medical
• 11.17 Stevanato Group
• 11.18 Epsilon Electronics

List of Tables

• Table 1 Global Drug Delivery Pump Electronics Market Outlook, By Region (2023-2034) ($MN)
• Table 2 Global Drug Delivery Pump Electronics Market Outlook, By Pump Type (2023-2034) ($MN)
• Table 3 Global Drug Delivery Pump Electronics Market Outlook, By Syringe Pumps (2023-2034) ($MN)
• Table 4 Global Drug Delivery Pump Electronics Market Outlook, By Infusion Pumps (2023-2034) ($MN)
• Table 5 Global Drug Delivery Pump Electronics Market Outlook, By Implantable Pumps (2023-2034) ($MN)
• Table 6 Global Drug Delivery Pump Electronics Market Outlook, By Insulin Pumps (2023-2034) ($MN)
• Table 7 Global Drug Delivery Pump Electronics Market Outlook, By Elastomeric Pumps (2023-2034) ($MN)
• Table 8 Global Drug Delivery Pump Electronics Market Outlook, By Application (2023-2034) ($MN)
• Table 9 Global Drug Delivery Pump Electronics Market Outlook, By Diabetes Management (2023-2034) ($MN)
• Table 10 Global Drug Delivery Pump Electronics Market Outlook, By Oncology (2023-2034) ($MN)
• Table 11 Global Drug Delivery Pump Electronics Market Outlook, By Pain Management (2023-2034) ($MN)
• Table 12 Global Drug Delivery Pump Electronics Market Outlook, By Cardiovascular Disorders (2023-2034) ($MN)
• Table 13 Global Drug Delivery Pump Electronics Market Outlook, By Neurology (2023-2034) ($MN)
• Table 14 Global Drug Delivery Pump Electronics Market Outlook, By Gastroenterology (2023-2034) ($MN)
• Table 15 Global Drug Delivery Pump Electronics Market Outlook, By Infectious Diseases (2023-2034) ($MN)
• Table 16 Global Drug Delivery Pump Electronics Market Outlook, By End User (2023-2034) ($MN)
• Table 17 Global Drug Delivery Pump Electronics Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
• Table 18 Global Drug Delivery Pump Electronics Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
• Table 19 Global Drug Delivery Pump Electronics Market Outlook, By Home Care Settings (2023-2034) ($MN)
• Table 20 Global Drug Delivery Pump Electronics Market Outlook, By Specialty Centers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.